Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Kai'anchen Pharmaceutical Technology is a specialized pharmaceutical enterprise based in the Wuhan East Lake High-tech Development Zone, China. The company focuses on the research, development, and production of high-end pharmaceutical intermediates and active pharmaceutical ingredients (APIs). They provide a comprehensive suite of services including custom synthesis, process development, and contract manufacturing for the global life sciences industry. Their technical expertise is primarily centered on small molecule chemistry, supporting the development of therapies in areas such as cardiovascular health and oncology. Kai'anchen operates as a strategic supplier, offering high-purity chemical building blocks to pharmaceutical companies and research institutions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Kai'anchen Pharmaceutical Technology.